The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistanceHatim Sati, Elena Carrara, Alessia Savoldi et al.|The Lancet Infectious Diseases|2025Cited by 526
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is neededMark S. Butler, Peter Beyer, Christian Lienhardt et al.|Archive ouverte UNIGE (University of Geneva)|2022Cited by 221
The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipelineIsabel Frost, Peter Beyer, Hatim Sati et al.|The Lancet Microbe|2022Cited by 182
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)FT. Musuamba, Ine Skottheim Rusten, Efthymios Manolis et al.|CPT Pharmacometrics & Systems Pharmacology|2017Cited by 68
<i>Candida auris</i>—a systematic review to inform the world health organization fungal priority pathogens listHannah Yejin Kim, Jan‐Willem C. Alffenaar, Thi Anh Nguyen et al.|Medical Mycology|2024Cited by 60